Strong immune response and protection against Brucella abortus by Omp25 and BP26 mRNA vaccine candidates
International Immunopharmacology · 2025-06 · 158 · 114765
DOI: 10.1016/j.intimp.2025.114765 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-06. Verfasst von Xuyan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hebei GEO University, Shijiazhuang 050031, China. Electronic address: xclxy0203@163.com. Hauptthemen laut MEDLINE: Brucella abortus, Brucellosis, Brucella Vaccine, Bacterial Outer Membrane Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Department of Education of Hebei Province, Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Brucellosis, a globally prevalent zoonotic disease caused by Brucella species, remains without safe and effective human vaccines. This study focuses on the outer membrane proteins Omp25 and BP26 of Brucella as targets, employing a multidimensional strategy to develop novel mRNA vaccines and systematically evaluate their immunoprotective efficacy. First, bioinformatics tools were used to predict the antigenicity, immunogenicity, and physicochemical properties of Omp25 and BP26, while the C-ImmSim server simulated their potential to induce innate and adaptive immune responses. Building on these predictions, we designed and synthesized lipid nanoparticle-encapsulated nucleoside-modified mRNA vaccines (Omp25-Fc and BP26-Fc mRNA-LNPs) and compared their immunogenicity with traditional alum-adjuvanted protein vaccines (alum-BP26 and alum-Omp25). Animal experiments demonstrated that three immunizations with Omp25-Fc and BP26-Fc mRNA-LNPs induced significantly stronger humoral and cellular immune responses in mice compared to conventional vaccines. Evaluation of protective efficacy through challenge experiments revealed a marked reduction in splenic bacterial load in both mRNA vaccine groups relative to the controls. Mechanistic analysis further showed that Omp25-Fc and BP26-Fc mRNA vaccines activated mixed Th1/Th2 immune responses, effectively reducing bacterial burden and inflammatory damage in systemic infection models. Notably, the mRNA vaccines exhibited more durable immune memory and broader protective coverage than the alum-adjuvanted protein vaccines. Our findings demonstrate that Omp25- and BP26-based mRNA-LNP vaccines exhibit high immunogenicity and clinical translational potential, providing innovative strategies and experimental evidence for the development of brucellosis vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei GEO University, Shijiazhuang 050031, China. Electronic address: xclxy0203@163.com.
- CSPC Megalith Biopharmaceutical Co. Ltd, Shijiazhuang 050051, China.
- School of Chemistry & Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.
- School of Chemistry & Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China. Electronic address: Zhaoyunwang1234@163.com.
- Qinhuangdao First Hospital affiliated to Hebei Medical University, Qinhuangdao 066000, China.
Förderung
- Department of Education of Hebei Province
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Hebei GEO University
Zitieren
APA
Liu, X., Xiu, C., He, L., Zhao, Y., & Li, B. (2025). Strong immune response and protection against Brucella abortus by Omp25 and BP26 mRNA vaccine candidates. International Immunopharmacology, 158, 114765. https://doi.org/10.1016/j.intimp.2025.114765
Vancouver
Liu X, Xiu C, He L, Zhao Y, Li B. Strong immune response and protection against Brucella abortus by Omp25 and BP26 mRNA vaccine candidates. International Immunopharmacology. 2025;158:114765. doi:10.1016/j.intimp.2025.114765
BibTeX
@article{Liu2025,
author = {Liu, Xuyan and Xiu, Chenlin and He, Lei and Zhao, Yunwang and Li, Baolin},
title = {Strong immune response and protection against Brucella abortus by Omp25 and BP26 mRNA vaccine candidates},
journal = {International Immunopharmacology},
year = {2025},
volume = {158},
pages = {114765},
doi = {10.1016/j.intimp.2025.114765}
}
EUVIMED